Cong Xu

Cong (Tony) Xu is a co-founder and Chief Operating Officer at Drug Farm, a biotech company specializing in first-in-class drug development for oncology, infection, autoimmune, and inflammatory diseases since September 2015. Drug Farm's innovative IDInVivo platform utilizes breakthrough technology in mouse genetics to discover new drug targets in living mice. Prior to Drug Farm, Cong Xu worked as a consultant at L.E.K. Consulting from September 2012 to August 2015 and completed a Doctor of Philosophy (PhD) in Biotechnology with a focus on Stem Cell at Harvard University from 2007 to 2012. Additionally, education includes an advanced program at Harvard Business School from 2010 to 2011 and a Bachelor of Science (B.S.) in Biological Sciences from Fudan University, earned in 2007.